MiR-125a-5p Regulates Differential Activation of Macrophages and Inflammation

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2013 Oct 24

PMID 24151079

Citations 132

Authors

Sami Banerjee

Huachun Cui

Na Xie

Zheng Tan

Shanzhong Yang

Mert Icyuz

Victor John Thannickal

Edward Abraham

Gang Liu

Affiliations

Soon will be listed here.

Abstract

Macrophage activation is a central event in immune responses. Macrophages undergoing classical activation (M1 macrophages) are proinflammatory, whereas alternatively activated macrophages (M2 macrophages) are generally anti-inflammatory. miRNAs play important regulatory roles in inflammatory response. However, the manner in which miRNAs regulate macrophage activation in response to different environmental cues has not been well defined. In this study, we found that M-BMM macrophages (M2) express greater levels of miR-125a-5p than do GM-BMM macrophages (M1). Stimulation of macrophages through TLR2 and TLR4 but not through TLR3 enhanced miR-125a-5p expression. Up-regulation of miR-125a-5p after TLR2/4 activation requires the adaptor MYD88 but not TRIF. Overexpression of miR-125a-5p diminished M1 phenotype expression induced by LPS but promoted M2 marker expression induced by IL-4. In contrast, knockdown of miR-125a-5p promoted M1 polarization and diminished IL-4-induced M2 marker expression. We found that miR-125a-5p targets KLF13, a transcriptional factor that has an important role in T lymphocyte activation and inflammation. KLF13 knockdown had similar effects on M1 activation as did miR-125a-5p overexpression. In addition, miR-125a-5p regulates phagocytic and bactericidal activities of macrophages. Our data suggest that miR-125a-5p has an important role in suppressing classical activation of macrophages while promoting alternative activation.

Citing Articles

Development of a macrophage polarization-modulating therapeutic agent for osteoarthritis treatment.

Wu L, Cao X, Shen B J Orthop Surg Res. 2025; 20(1):279.

PMID: 40082923 PMC: 11908040. DOI: 10.1186/s13018-025-05679-2.

Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.

Teo L, Juantuah-Kusi N, Subramanian G, Sampath P Noncoding RNA. 2025; 11(1).

PMID: 39997616 PMC: 11858470. DOI: 10.3390/ncrna11010016.

Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis.

Figueroa-Valdes A, Luz-Crawford P, Herrera-Luna Y, Georges-Calderon N, Garcia C, Tobar H J Nanobiotechnology. 2025; 23(1):13.

PMID: 39806427 PMC: 11730155. DOI: 10.1186/s12951-024-03088-x.

Role of M1/M2 macrophages in pain modulation.

Zhu X, Chen S, Xie Y, Cheng Z, Zhu X, Guo Q Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(7):1155-1163.

PMID: 39788503 PMC: 11495980. DOI: 10.11817/j.issn.1672-7347.2024.240017.

Exploring microRNA signatures in pediatric non-infectious uveitis: meta-analysis and molecular profiling of patient samples.

Wawrzyniak O, Wawrzyniak D, Smuszkiewicz M, Glodowicz P, Gotz-Wieckowska A, Rolle K J Appl Genet. 2024; .

PMID: 39695050 DOI: 10.1007/s13353-024-00922-8.

References

Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N . IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011; 12(3):231-8. DOI: 10.1038/ni.1990. View

Nikolcheva T, Pyronnet S, Chou S, Sonenberg N, Song A, Clayberger C . A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes. J Clin Invest. 2002; 110(1):119-26. PMC: 151028. DOI: 10.1172/JCI15336. View

Martinez F, Gordon S, Locati M, Mantovani A . Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006; 177(10):7303-11. DOI: 10.4049/jimmunol.177.10.7303. View

Akira S, Takeda K . Toll-like receptor signalling. Nat Rev Immunol. 2004; 4(7):499-511. DOI: 10.1038/nri1391. View

Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H . Krüppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011; 121(7):2736-49. PMC: 3223832. DOI: 10.1172/JCI45444. View

Zhuang G, Meng C, Guo X, Cheruku P, Shi L, Xu H . A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation. 2012; 125(23):2892-903. DOI: 10.1161/CIRCULATIONAHA.111.087817. View

Mullican S, Gaddis C, Alenghat T, Nair M, Giacomin P, Everett L . Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 2011; 25(23):2480-8. PMC: 3243058. DOI: 10.1101/gad.175950.111. View

Arranz A, Doxaki C, Vergadi E, Martinez De La Torre Y, Vaporidi K, Lagoudaki E . Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A. 2012; 109(24):9517-22. PMC: 3386059. DOI: 10.1073/pnas.1119038109. View

Kim S, Ramasamy K, Bouamar H, Lin A, Jiang D, Aguiar R . MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci U S A. 2012; 109(20):7865-70. PMC: 3356650. DOI: 10.1073/pnas.1200081109. View

10.

Rajaram M, Ni B, Morris J, Brooks M, Carlson T, Bakthavachalu B . Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci U S A. 2011; 108(42):17408-13. PMC: 3198317. DOI: 10.1073/pnas.1112660108. View

11.

Graff J, Dickson A, Clay G, McCaffrey A, Wilson M . Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem. 2012; 287(26):21816-25. PMC: 3381144. DOI: 10.1074/jbc.M111.327031. View

12.

ONeill L . How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol. 2005; 18(1):3-9. DOI: 10.1016/j.coi.2005.11.012. View

13.

Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal V . miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010; 207(8):1589-97. PMC: 2916139. DOI: 10.1084/jem.20100035. View

14.

Barton G, Medzhitov R . Toll-like receptor signaling pathways. Science. 2003; 300(5625):1524-5. DOI: 10.1126/science.1085536. View

15.

Kim D, Zhang W, Millman S, Hwang B, Kwon S, Clayberger C . Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes. Blood. 2012; 120(8):1658-67. PMC: 3429307. DOI: 10.1182/blood-2012-03-415968. View

16.

Fleetwood A, Dinh H, Cook A, Hertzog P, Hamilton J . GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol. 2009; 86(2):411-21. DOI: 10.1189/jlb.1108702. View

17.

Song A, Chen Y, Thamatrakoln K, Storm T, Krensky A . RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity. 1999; 10(1):93-103. DOI: 10.1016/s1074-7613(00)80010-2. View

18.

Ponomarev E, Veremeyko T, Barteneva N, Krichevsky A, Weiner H . MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat Med. 2010; 17(1):64-70. PMC: 3044940. DOI: 10.1038/nm.2266. View

19.

Monk C, Hutvagner G, Arthur J . Regulation of miRNA transcription in macrophages in response to Candida albicans. PLoS One. 2010; 5(10):e13669. PMC: 2965114. DOI: 10.1371/journal.pone.0013669. View

20.

Stefani G, Slack F . Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008; 9(3):219-30. DOI: 10.1038/nrm2347. View